Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.40 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 2/20 | 0.35 |
| ▸ | PPARA | Q07869 | 2/20 | 0.35 |
| ▸ | SCD | O00767 | 1/20 | 0.35 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL2364277 | 0.94 | TRPM8 (0.44) | TRPM8SIGMAR1EPHX2DRD2HTR2A | |
| SCHEMBL8410197 | 0.81 | TRPM8 (0.49) | TRPM8SIGMAR1EPHX2DRD2HTR2A | |
| SCHEMBL15882569 | 0.79 | TRPM8 (0.48) | TRPM8SIGMAR1EPHX2DRD2HTR2A | |
| SCHEMBL29455981 | 0.78 | TRPM8 (0.47) | TRPM8SIGMAR1PPARGPPARA | |
| SCHEMBL3519974 | 0.78 | TRPM8 (0.47) | TRPM8SIGMAR1PPARGPPARA | |
| SCHEMBL4551228 | 0.77 | TRPM8 (0.46) | TRPM8SIGMAR1EPHX2DRD2HTR2A | |
| SCHEMBL462820 | 0.76 | SIGMAR1 (0.45) | TRPM8SIGMAR1EPHX2DRD2HTR2A | |
| SCHEMBL6467973 | 0.76 | SIGMAR1 (0.45) | TRPM8SIGMAR1EPHX2DRD2HTR2A | |
| SCHEMBL30613915 | 0.74 | PPARG (0.59) | TRPM8SIGMAR1PPARGPPARA | |
| SCHEMBL16635226 | 0.74 | PPARG (0.59) | TRPM8SIGMAR1PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-57145871-A | — | — | None | — | — | JP | disclosed |
| WO-2024010441-A1 | A SELF-EMULSIFYING DRUG DELIVERY FORMULATION WITH IMPROVED ORAL BIOAVAILABILITY OF LIPOPHILIC COMPOUND | AVANTSAR SDN BHD (MY) | 2024-01-11 | — | — | WO | disclosed |
| US-20220160759-A1 | NOVEL COMPOSITIONS FOR TREATING COLITIS AND/OR PREVENTING COLON CANCER | PURDUE RESEARCH FOUNDATION (US) | 2022-05-26 | — | — | US | disclosed |
| CN-108349929-B | Tocotrienol derivatives, pharmaceutical compositions and methods of use in 5-lipoxygenase related disorders | 昂热大学 | 2022-01-11 | — | — | CN | disclosed |
| US-20190144413-A1 | TOCOTRIENOL DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD OF USE IN 5-LIPOXYGENASE RELATED DISEASES | FRIEDRICH-SCHILLER-UNIVERSITÄT JENA (DE) | 2019-05-16 | — | — | US | disclosed |
| EP-3341366-A1 | TOCOTRIENOL DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD OF USE IN 5-LIPOXYGENASE RELATED DISEASES | Université d'Angers (FR) | 2018-07-04 | — | — | EP | disclosed |
| US-20170296505-A1 | LONG-CHAIN CARBOXYCHROMANOLS AND ANALOGS FOR USE AS ANTI-INFLAMMATORY AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2017-10-19 | — | — | US | disclosed |
| US-20170296505-A1 | LONG-CHAIN CARBOXYCHROMANOLS AND ANALOGS FOR USE AS ANTI-INFLAMMATORY AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2017-10-19 | — | — | US | disclosed |
| US-9676744-B2 | Long-chain carboxychromanols and analogs for use as anti-inflammatory agents | PURDUE RESEARCH FOUNDATION (US) | 2017-06-13 | — | — | US | disclosed |
| US-9676744-B2 | Long-chain carboxychromanols and analogs for use as anti-inflammatory agents | PURDUE RESEARCH FOUNDATION (US) | 2017-06-13 | — | — | US | disclosed |
| US-8822529-B2 | Long-chain carboxychromanols and analogs for use as anti-inflammatory agents | PURDUE RESEARCH FOUNDATION (US) | 2014-09-02 | — | — | US | disclosed |
| US-8822529-B2 | Long-chain carboxychromanols and analogs for use as anti-inflammatory agents | PURDUE RESEARCH FOUNDATION (US) | 2014-09-02 | — | — | US | disclosed |
| US-20110207808-A1 | LONG-CHAIN CARBOXYCHROMANOLS AND ANALOGS FOR USE AS ANTI-INFLAMMATORY AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2011-08-25 | — | — | US | disclosed |
| US-20110207808-A1 | LONG-CHAIN CARBOXYCHROMANOLS AND ANALOGS FOR USE AS ANTI-INFLAMMATORY AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2011-08-25 | — | — | US | disclosed |
| WO-2010033687-A1 | LONG-CHAIN CARBOXYCHROMANOLS AND ANALOGS FOR USE AS ANTI-INFLAMMATORY AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2010-03-25 | — | — | WO | disclosed |
| WO-2010033687-A1 | LONG-CHAIN CARBOXYCHROMANOLS AND ANALOGS FOR USE AS ANTI-INFLAMMATORY AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2010-03-25 | — | — | WO | disclosed |
| EP-1178994-B1 | IMPROVED PROCESS FOR PHOSPHORYLATION | VITAL HEALTH SCIENCES PTY LTD (AU) | 2007-10-31 | — | — | EP | disclosed |
| US-5348973-A | Resolution of hydroxychroman-2-carboxylic acid esters by enantiomeric hydrolysis | RHONE-POULENC CHIMIE (FR) | 1994-09-20 | — | — | US | disclosed |
| EP-0183869-B1 | CHROMAN COMPOUNDS AND THEIR USE | KURARAY CO., LTD. (JP) | 1991-04-17 | — | — | EP | disclosed |
| JP-S57145871-A | CHROMANOLCARBOXYLIC DERIVATIVE | EISAI CO LTD | 1982-09-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190144413-A1 | TOCOTRIENOL DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD OF USE IN 5-LIPOXYGENASE RELATED DISEASES | ALOX5, ALOX15B, ALOX15 | TRPM8 1719/4885SIGMAR1 3053/4885EPHX2 122/4885 |
| US-20110207808-A1 | LONG-CHAIN CARBOXYCHROMANOLS AND ANALOGS FOR USE AS ANTI-INFLAMMATORY AGENTS | ALOX12, ALOX5, ALOX15 | TRPM8 3243/4885SIGMAR1 1228/4885EPHX2 50/4885 |
| US-20170296505-A1 | LONG-CHAIN CARBOXYCHROMANOLS AND ANALOGS FOR USE AS ANTI-INFLAMMATORY AGENTS | ALOX12, ALOX5, PTGS1 | TRPM8 3141/4885SIGMAR1 1154/4885EPHX2 55/4885 |
| US-20220160759-A1 | NOVEL COMPOSITIONS FOR TREATING COLITIS AND/OR PREVENTING COLON CANCER | LBR, LTA, IL23R | TRPM8 4110/4885SIGMAR1 1665/4885EPHX2 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.